Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiac substructure delineation in radiation therapy - A state-of-the-art review.
Finnegan RN, Quinn A, Booth J, Belous G, Hardcastle N, Stewart M, Griffiths B, Carroll S, Thwaites DI. Finnegan RN, et al. Among authors: hardcastle n. J Med Imaging Radiat Oncol. 2024 May 17. doi: 10.1111/1754-9485.13668. Online ahead of print. J Med Imaging Radiat Oncol. 2024. PMID: 38757728 Review.
Functional lung avoidance planning using Multi-Criteria Optimisation.
Bucknell N, Hardcastle N, McIntosh L, Ball D, Hofman MS, Kron T, Siva S. Bucknell N, et al. Among authors: hardcastle n. Pract Radiat Oncol. 2024 May 3:S1879-8500(24)00095-X. doi: 10.1016/j.prro.2024.04.014. Online ahead of print. Pract Radiat Oncol. 2024. PMID: 38705233
Dose-effect Relationship of Kidney Function After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: Trog 15.03 Fastrack Ii.
Gaudreault M, Hardcastle N, Jackson P, McIntosh L, Higgs B, Pryor D, Sidhom M, Dykyj R, Moore A, Kron T, Siva S. Gaudreault M, et al. Among authors: hardcastle n. Int J Radiat Oncol Biol Phys. 2024 Apr 26:S0360-3016(24)00564-9. doi: 10.1016/j.ijrobp.2024.04.066. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38679212
Partially Ablative Body Radiotherapy (PABR): A novel approach for palliative radiotherapy of locally advanced bulky unresectable sarcomas.
Yu KK, Yeo A, Ngan S, Chu J, Chang D, Siva S, Wong A, Kron T, Hardcastle N, Gaudreault M, Chesson T, Williams S, Burns M, Chander S. Yu KK, et al. Among authors: hardcastle n. Radiother Oncol. 2024 Apr 21:110275. doi: 10.1016/j.radonc.2024.110275. Online ahead of print. Radiother Oncol. 2024. PMID: 38653378 No abstract available.
Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial.
Steinfort DP, Kothari G, Wallace N, Hardcastle N, Rangamuwa K, Dieleman EMT, Lee P, Li P, Simpson JA, Yo S, Bashirdazeh F, Nguyen P, Jennings BR, Fielding D, Crombag L, Irving LB, Yasufuku K, Annema JT, Ost DE, Siva S. Steinfort DP, et al. Among authors: hardcastle n. Lancet Respir Med. 2024 Mar 11:S2213-2600(24)00010-9. doi: 10.1016/S2213-2600(24)00010-9. Online ahead of print. Lancet Respir Med. 2024. PMID: 38490228
Multi-centre evaluation of variation in cumulative dose assessment in reirradiation scenarios.
Hardcastle N, Vasquez Osorio E, Jackson A, Mayo C, Aarberg AE, Ayadi M, Belosi F, Ceylan C, Davey A, Dupuis P, Handley JC, Hemminger T, Hoffmann L, Kelly C, Michailidou C, Muscat S, Murrell DH, Pérez-Alija J, Palmer C, Placidi L, Popovic M, Rønde HS, Selby A, Skopidou T, Solomou N, Stroom J, Thompson C, West NS, Zaila A, Appelt AL. Hardcastle N, et al. Radiother Oncol. 2024 May;194:110184. doi: 10.1016/j.radonc.2024.110184. Epub 2024 Mar 5. Radiother Oncol. 2024. PMID: 38453055 Free article.
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
Siva S, Bressel M, Sidhom M, Sridharan S, Vanneste BGL, Davey R, Montgomery R, Ruben J, Foroudi F, Higgs B, Lin C, Raman A, Hardcastle N, Hofman MS, De Abreu Lourenco R, Shaw M, Mancuso P, Moon D, Wong LM, Lawrentschuk N, Wood S, Brook NR, Kron T, Martin J, Pryor D; FASTRACK II Investigator Group. Siva S, et al. Among authors: hardcastle n. Lancet Oncol. 2024 Mar;25(3):308-316. doi: 10.1016/S1470-2045(24)00020-2. Lancet Oncol. 2024. PMID: 38423047 Clinical Trial.
171 results